Methods and reagents for vaccination which generate CD8 T cell immune response

Details for Australian Patent Application No. 2004203141 (hide)

Owner Oxxon Therapeutics Limited

Inventors Blanchard, Tom; Plebanski, Magdalena; Smith, Geoffrey Lilly; McMichael, Andrew James; Gilbert, Sarah Catherine; Hanke, Tomas; Hill, Adrian Vivian Sinton; Schneider, Joerg

Agent Watermark

Pub. Number AU-B-2004203141

Parent 775973

Filing date 9 July 2004

Wipo publication date 5 August 2004

Acceptance publication date 20 September 2007

International Classifications

C12N 15/30 (2006.01) Mutation or genetic engineering - Genes encoding protozoal proteins, e.g. from Plasmodium, Trypanosoma, Eimeria

A61K 39/015 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

29 July 2004 Complete Application Filed

5 August 2004 Application Open to Public Inspection

  Published as AU-B-2004203141

20 September 2007 Application Accepted

  Published as AU-B-2004203141

17 January 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004203142-Turbogrille air diffuser

2004203140-Method for controlling breeding of freerange animals